ARCHIVES

AZT, DDC Combination Increase CD4 Counts, NIAID Trial Finds

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

January 31, 1992

New Treatments And Quality of Life Study For Ovarian Cancer Described At SGO

March 26, 2004

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993

House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI

August 7, 1992

Avastin Increases Overall Survival 3.7 Months

February 22, 2013

In Brief: Myers, Whang-Peng, Zink Leaving NCU; FDA Hires New Legislative Affairs Chief

February 18, 1994